April/May NDAs

The FDA has approved the following drugs in April and May:

  • Taclonex Scalp Suspension (calcipotriene; betamethasone diproprionate) details
  • A variety of cetirizine products from various vendors continues to enter the marketplace.
  • Patanase nasal spray (olapatadine) detail
  • Treximet (sumatriptan/naproxen sodium) detail
  • Aplenzin (buproprion hydrobromide) detail

0 Responses to “April/May NDAs”


Comments are currently closed.